COMPETE P2030: Bio-Transfer Project Approved to Strengthen Biomedical Commercialisation - AccelBio

Under COMPETE P2030, AccelBio has secured approval for Bio-Transfer: Biomedical Knowledge Commercialization Program, a joint initiative led by i3S, AccelBio, and CoLAB Trials.